Adam Tucker1, Kevin J Donnelly1, Clare Rowan2, Sinead McDonald3, Andrew P Foster1. 1. Department of Trauma and Orthopaedics, Altnagelvin Area Hospital, Londonderry, Northern Ireland. 2. Department of Trauma and Orthopaedics, Royal Victoria Hospital, Belfast, Northern Ireland. 3. Fracture Outcomes and Research Department (FORD), Royal Victoria Hospital, Belfast, Northern Ireland.
Abstract
OBJECTIVES: To evaluate the functional outcomes, revision, and mortality rates of 3 implants used for unstable intertrochanteric hip fractures; the sliding hip screw (SHS), with or without a trochanteric stabilization plate (TSP); and a cephalomedullary nail (CMN). DESIGN: Multicentre National Prospective Cohort Study. SETTING: Northern Ireland. PATIENT/PARTICIPANTS: Patients were identified from a prospective database. Fractures were classified according to OTA/AO A31A2.2, A2.3, and A3. All patients had a minimum of 12 months of follow-up. INTERVENTION: Patients received either an SHS, an SHS in combination with a TSP, or a CMN. Implant choice was at the discretion of the operating surgeon. OUTCOME MEASURE: Primary outcome was 12-month mortality analyzed by the Kaplan-Meier survival analysis. Secondary outcomes included 12-month functional status using a validated score and all time revision of implants for any reason. RESULTS: In total, 3230 patients met the inclusion criteria (2474 SHS, 158 SHS + TSP, and 598 CMN). CMN use increased over time, with concomitant reduction in SHS use. There was no significant difference in functional outcomes at 12 months (analysis of variance, P = 0.177). Although men were significantly younger, they were at a higher risk of 12-month mortality. CMNs had statistically significantly lower 12-month mortality rates (P = 0.0148). The highest revision rate (4.04%) was seen in patients treated with SHS alone (P = 0.041). CONCLUSIONS: The use of a CMN in unstable intertrochanteric hip fractures conveys the best results in functional outcomes, 12-month mortality, and has lower revision rates compared with an SHS ± TSP. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
OBJECTIVES: To evaluate the functional outcomes, revision, and mortality rates of 3 implants used for unstable intertrochanteric hip fractures; the sliding hip screw (SHS), with or without a trochanteric stabilization plate (TSP); and a cephalomedullary nail (CMN). DESIGN: Multicentre National Prospective Cohort Study. SETTING: Northern Ireland. PATIENT/PARTICIPANTS: Patients were identified from a prospective database. Fractures were classified according to OTA/AO A31A2.2, A2.3, and A3. All patients had a minimum of 12 months of follow-up. INTERVENTION: Patients received either an SHS, an SHS in combination with a TSP, or a CMN. Implant choice was at the discretion of the operating surgeon. OUTCOME MEASURE: Primary outcome was 12-month mortality analyzed by the Kaplan-Meier survival analysis. Secondary outcomes included 12-month functional status using a validated score and all time revision of implants for any reason. RESULTS: In total, 3230 patients met the inclusion criteria (2474 SHS, 158 SHS + TSP, and 598 CMN). CMN use increased over time, with concomitant reduction in SHS use. There was no significant difference in functional outcomes at 12 months (analysis of variance, P = 0.177). Although men were significantly younger, they were at a higher risk of 12-month mortality. CMNs had statistically significantly lower 12-month mortality rates (P = 0.0148). The highest revision rate (4.04%) was seen in patients treated with SHS alone (P = 0.041). CONCLUSIONS: The use of a CMN in unstable intertrochanteric hip fractures conveys the best results in functional outcomes, 12-month mortality, and has lower revision rates compared with an SHS ± TSP. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
Authors: Carl Erik Alm; Frede Frihagen; Eva Dybvik; Kjell Matre; Jan Erik Madsen; Jan-Erik Gjertsen Journal: J Orthop Surg Res Date: 2021-01-07 Impact factor: 2.359
Authors: Olof Wolf; Sebastian Mukka; Jan Ekelund; Cecilia Rogmark; Michael Möller; Nils P Hailer Journal: Acta Orthop Date: 2022-01-03 Impact factor: 3.717
Authors: Carl Erik Alm; Jan-Erik Gjertsen; Trude Basso; Kjell Matre; Stephan Rörhl; Jan Erik Madsen; Frede Frihagen Journal: Acta Orthop Date: 2021-07-23 Impact factor: 3.717